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Abstract Surveillance of nosocomial infection is the
foundation of infection control. Nosocomial infection sur-
veillance data ought to be summarized, reported, and fed
back to health care personnel for corrective action. Using
the Japanese Nosocomial Infection Surveillance (JANIS)
data, we determined the incidence of nosocomial infections
in intensive care units (ICUs) of Japanese hospitals and
assessed the impact of nosocomial infections on mortality
and length of stay. We also elucidated individual and
environmental factors associated with nosocomial infec-
tions, examined the benchmarking of infection rates and
developed a practical tool for comparing infection rates
with case-mix adjustment. The studies carried out to date
using the JANIS data have provided valuable information
on the epidemiology of nosocomial infections in Japanese
ICUs, and this information will contribute to the develop-
ment of evidence-based infection control programs for
Japanese ICUs. We conclude that current surveillance
systems provide an inadequate feedback of nosocomial
infection surveillance data and, based on our results, sug-
gest a methodology for assessing nosocomial infection
surveillance data that will allow infection control
professionals to maintain their surveillance systems in
good working order.
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Introduction
Infection control in the hospital setting is performed with
the aim of improving the effectiveness of patient care and
promoting patient safety. Infection control professionals
need to recognize and explain nosocomial infections and
design and implement interventions to reduce their inci-
dence. These infection control activities should have their
bases in a well-designed surveillance system of nosocomial
infections [1].
Compared with the USA and other developed countries,
Japan traditionally had limited sources of information on
the epidemiology of nosocomial infections and, until
recently, little was known about the incidence and outcome
of nosocomial infections in Japanese hospitals. The Japa-
nese Ministry of Health, Labour, and Welfare established
the Japanese Nosocomial Infection Surveillance (JANIS)
system in July 2000, when participating hospitals routinely
started to collect and subsequently make their nosocomial
infection surveillance data available for entry into a
national database. The JANIS database has now become
the most important source of information on the epidemi-
ology of nosocomial infections in Japanese hospitals.
In the study reported here, we used the JANIS data to
determine the incidence of nosocomial infections in
intensive care units (ICUs) of Japanese hospitals and assess
the impact of nosocomial infections on mortality and
length of stay. We elucidated individual and environmental
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allowed us to identify high-risk patients and take appro-
priate measures to prevent infection. Infection rates are
calculated as a fundamental measure for surveillance of
nosocomial infections. The comparison of infection rates
between hospitals and within a hospital over time con-
tributes to the improved design, implementation and
evaluation of infection control programs [2, 3]. We
examined the benchmarking of infection rates and devel-
oped a practical tool for comparing infection rates with
case-mix adjustment.
The JANIS system
The ICU component of the JANIS system consists of more
than 30 ICUs of multidisciplinary hospitals throughout
Japan that have more than 200 beds. All of the patients
admitted to the participating ICUs are automatically
enrolled in the survey. The following data are collected by
trained physicians and nurses in each ICU and sent to the
data management ofﬁce by the Internet on a monthly basis:
sex, age, underlying disease, severity-of-illness [4], ICU
admission and discharge (date, time and route), operation
(elective and urgent), device use (ventilator, urinary cath-
eter and central venous catheter), infection (pneumonia,
urinary tract infection, catheter-related bloodstream infec-
tion, sepsis, wound infection and others) and hospital
discharge (date and outcome). APACHE II uses a point
score based on the initial values of 12 routine physiological
measurements, age and previous health status to provide a
general measure of severity of illness [4]. A higher point
score indicates a greater mortality risk. Infections are
diagnosed according to the JANIS criteria [5], which are
based on and modiﬁed from those of the National Noso-
comial Infections Surveillance (NNIS) system in the USA
[6]. Nosocomial (ICU-acquired) infection is deﬁned as a
newly developed infection at least 2 days after ICU
admission [6]. Pathogens are classiﬁed as drug resistant or
drug susceptible according to the JANIS deﬁnitions that
specify a drug-resistance pattern for each pathogen [5].
The JANIS system takes various measures to establish a
standardized and formatted database: a speciﬁc database-
oriented software and a written operating manual with
uniform deﬁnitions and surveillance protocols are prepared
in advance; workshops for data collectors are conducted on
demand; reliability checks are routinely performed at the
data management ofﬁce. Although the participating ICUs
may not represent all Japanese ICUs, the JANIS data is the
only reliable source of information on the epidemiology of
nosocomial infections inJapanese ICUs. Comparedwith the
NNIS system, the JANIS system has the advantage of col-
lecting data from each patient.The availability of the JANIS
data enabled us to assess the incidence and outcome of
nosocomial infections in the context of individual factors.
Epidemiology of nosocomial infections
in Japanese ICUs
Incidence of nosocomial infections
Figure 1 shows the incidence of nosocomial infections in
Japanese ICUs [7]. The study cohort consisted of 7374
Fig. 1 Incidence of nosocomial
infections (%) in Japanese
intensive care units (ICUs) from
July 2000 to May 2002.
Pathogens were classiﬁed as
drug resistant (ﬁlled bar)o r
drug susceptible (shaded bar)
according to the JANIS
deﬁnitions
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ized in 34 ICUs for C48 h. Of these 7374 patients, 678
patients (9.2%) had had at least one episode of nosocomial
infection. The most common nosocomial infection was
pneumonia (517 cases, 64%), followed by sepsis (106
cases, 13%), wound infection (102 cases, 13%), urinary
tract infection (43 cases, 5%) and catheter-related blood-
stream infection (42 cases, 5%). Drug-resistant pathogens
were detected in 201 patients with nosocomial infection
(29.6%). The majority of drug-resistant pathogens were
methicillin-resistant staphylococcus aureus (MRSA).
A number of studies have been conducted to determine
the incidence of nosocomial infections in ICUs. However,
these studies differ considerably in terms of settings and
protocols and, therefore, it is difﬁcult to compare the
reported rates accurately, although the incidence of urinary
tract infection based on the NNIS data seems to be higher
than that based on the JANIS data (annual reports of the
JANIS system are available at: http://www.nih-janis.jp/
report/list_index.html).
Outcome of nosocomial infections
The same cohort data were analyzed to assess the impact of
nosocomial infections on hospital mortality [7, 8] and
length of hospital stay for survivors [8]. The crude hospital
mortality in the patients with nosocomial infection (45.8%
for the cases of drug-resistant pathogens, 36.1% for the
cases of drug-susceptible pathogens) was signiﬁcantly
higher than that in the patients without nosocomial infec-
tion (15.5%). Multivariate analysis adjusting for sex, age,
APACHE II score, operation and device use showed that
the patients with nosocomial infection caused by drug-
resistant pathogens had a 1.4-fold higher risk of hospital
mortality than those without nosocomial infection: the
adjusted hazard ratio [95% conﬁdence interval (CI)] of
nosocomial infections for hospital mortality was 1.42
(1.15–1.77) for the cases of drug-resistant pathogens and
1.11 (0.94–1.31) for the cases of drug-susceptible patho-
gens. The patients with nosocomial infection had a
signiﬁcantly longer hospital stay than the patients without
nosocomial infection. After adjusting for APACHE II
score, we estimated the excess length of the hospital stay
(95% CI) attributable to nosocomial infections to be 27.6
(18.6–36.5) days for the cases of drug-resistant pathogens
and 12.8 (8.2–17.4) days for the cases of drug-susceptible
pathogens.
Sepsis is a clinical syndrome describing infection and a
subsequent systemic inﬂammatory response [9, 10]. A
recent study of the JANIS data suggested that the devel-
opment of sepsis leads to additional increases in mortality
and length of stay among patients with nosocomial
infection in Japanese ICUs [11]. In a study cohort of
20,909 eligible patients aged C16 years, hospitalized in 28
ICUs for C24 h, there were 928 episodes of nosocomial
infection, including 168 episodes of sepsis (18.1%). The
standardized mortality ratio (95% CI) was estimated at 2.43
(1.88–3.09) in those patients with nosocomial infection and
subsequent sepsis and 1.18 (0.82–1.21) in those patients
with nosocomial infection only. The mean length of stay
(95% CI) following adjustment for the APACHE II score
was estimated to be 15.0 (13.3–17.0) days in patients with
nosocomial infection and subsequent sepsis and 11.8
(11.3–12.4) days in patients with nosocomial infection only
compared with 3.8 (3.8–3.9) days in patients without nos-
ocomial infection.
Factors associated with nosocomial infections
In order to implement interventions to reduce the incidence
of nosocomial infections, infection control professionals
need to understand factors associated with nosocomial
infections. The identiﬁcation of individual factors will
allow them to identify high-risk patients, and the identiﬁ-
cation of environmental factors will allow them to take
appropriate measures to prevent infection.
Individual factors
The study cohort data, consisting of 8587 eligible patients
aged C16 years who had been hospitalized in 34 ICUs for
C48 h, were analyzed to elucidate individual factors
associated with nosocomial infections [12]. Table 1 shows
the adjusted odds ratios for nosocomial infections. A
signiﬁcantly high odds ratio was found for APACHE II,
urgent operation, ventilator and central venous catheter,
while a signiﬁcantly low odds ratio was found for women
and elective operation. Although the impact of APACHE
II on the incidence of nosocomial infections became
weaker with longer ICU stay [13], APACHE II was rec-
ognized to be a good predictor of nosocomial infections.
Patients requiring particular attention from health care
workers to guard against infection are male, have a high
APACHE II score, have an urgent operation and use
ventilator and central venous catheter. Device use is the
major changeable risk factor for nosocomial infections
[14]. As mentioned above, pneumonia is the most com-
mon nosocomial infection in Japanese ICUs, and about
90% of episodes of pneumonia are associated with
mechanical ventilation [15]. Improvements in the man-
agement of ventilators should be given the highest priority
as a preventive measures against nosocomial infections in
Japanese ICUs.
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In 2001, 25 ICUs participating in the JANIS system took
part in a questionnaire survey on ICU characteristics. The
relationship between ICU characteristics and the incidence
of nosocomial infections was assessed to elucidate envi-
ronmental factors associated with nosocomial infections
[16]. The survey identiﬁed a number of ICU characteristics
associated with an increased incidence of nosocomial
infections, namely, the location of the ICU close by a
critical care center, resident physicians present for night
duty, ICU rounds conducted by attending physicians less
than once a day, case conferences held fewer than four
times a month, no local guidelines for antibiotic use,
common use of instruments and personnel not always using
gloves for patient care. Infection control professionals
should recognize the potential impacts of these factors on
the incidence of nosocomial infections and consider
implementing interventions to reduce the risk involved.
Assessment of nosocomial infection surveillance data
Infection rates are calculated as a fundamental measure for
surveillance of nosocomial infections. They must be
meaningful for comparison, either from one hospital to
another or within a hospital over time [2, 3]. A relatively
high or increased infection rate may suggest a potential
problem in the infection control program of the hospital,
while a relatively low or decreased infection rate may sug-
gest that the infection control program of the hospital is
successful in preventing infection. However, the distribu-
tion of risk factors for nosocomial infections varies widely
according to hospital and time. Failure to adjust adequately
for case-mix will lead to erroneous conclusions [2].
Benchmarking of infection rates is important when assess-
ingnosocomialinfectionsurveillancedata.Infectioncontrol
professionals fervently hope for a practical tool that allows
them to compare observed infection rates with external
standards (benchmark infection rates) in the proper way.
Benchmarking of infection rates
Infection rates are calculated as the total number of epi-
sodes of nosocomial infection divided by a measure of the
population at risk. The choice of the denominator is crucial
for interhospital comparison [2, 3]. The JANIS data has
been used to examine the distributions of several infection
rates with different denominators with the aim of identi-
fying the optimum denominator for comparing infection
rates between different Japanese ICUs [17]. Figure 2 shows
the distributions of infection rates (per admissions vs. per
patient-days) for pneumonia of 18 Japanese ICUs. These
varied widely according to the ICU, but all 18 ICUs were
assessed at the same order using either infection rate. The
infection rates per admissions and per patient-days were
signiﬁcantly correlated to each other (r = 0.99). Generally
speaking, infection rates per patient-days are a better tool
for carrying out interhospital comparison than infection
rates per admissions because the former can be adjusted for
length of stay [2]. It would be advisable to use infection
rates per patient-days for benchmarking in order to reduce
the risk of misleading.
A practical tool for comparing infection rates
with case-mix adjustment
A spreadsheet was developed to calculate the standardized
infection ratio (SIR) on the basis of the Japanese bench-
mark infection rates that were derived from the JANIS data
[18]. The SIR is a well-known risk-adjusted indicator that
is calculated by the indirect standardization method by
dividing the total number of observed nosocomial infec-
tions by the total number of expected nosocomial
infections [19]. The user of the spreadsheet inputs the
number of observed nosocomial infections and patient-days
Table 1 Adjusted odds ratios (ORs) with 95% conﬁdence intervals
(CIs) for nosocomial infection
Individual factors OR (95% CI)
Sex Men 1.00 (Reference)
Women 0.74 (0.62–0.88)
Age (years) 16–44 1.00 (Reference)
45–54 0.83 (0.60–1.15)
55–64 0.83 (0.62–1.12)
65–74 0.89 (0.68–1.18)
75+ 0.75 (0.56–1.00)
APACHE II 0–5 1.00 (Reference)
6–10 1.57 (1.03–2.40)
11–15 2.55 (1.70–3.85)
16–20 3.62 (2.39–5.49)
21–25 5.38 (3.50–8.27)
26–30 5.14 (3.23–8.16)
31+ 7.09 (4.34–11.59)
Operation None 1.00 (Reference)
Elective 0.78 (0.63–0.98)
Urgent 1.22 (1.00–1.49)
Ventilator Nonuser 1.00 (Reference)
User 2.11 (1.62–2.76)
Central venous catheter Nonuser 1.00 (Reference)
User 1.48 (1.14–1.93)
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a SIR adjusted for these three factors. A SIR value of more
than one indicates that the incidence of nosocomial infec-
tions in the ICU is higher than the benchmark. Figure 3
shows SIRs of eight Japanese ICUs. For example, ICU5,
ICU6 and ICU7 had a SIR of more than one in 2001. The
SIR of ICU5 was gradually decreasing in 2002 and 2003,
while, in contrast, those of ICU6 and ICU7 were increas-
ing. One interpretation of these results is that ICU5 was
successful in preventing infection while ICU6 and ICU7
had a potential problem in the infection control program
and, therefore, should at the very least investigate the cause
of the increasing incidence of nosocomial infection. The
spreadsheet is simple and easy enough to be used by all
infection control professionals, and it can reveal relative
merits and secular changes in the incidence of nosocomial
infections in the ICU. The use of the spreadsheet is
expected to promote timely feedback of nosocomial
infection surveillance data, which would allow infection
control professionals to take prompt and efﬁcient measures
to prevent infection.
Conclusion
The studies of the JANIS data provide valuable informa-
tion on the epidemiology of nosocomial infections in
Japanese ICUs, and this information will contribute to the
development of evidence-based infection control programs
for Japanese ICUs. The primary aim of the surveillance of
nosocomial infections is to introduce interventions aimed
at reducing the incidence of nosocomial infections.
Nosocomial infection surveillance data ought to be sum-
marized, reported and fed back to health care personnel for
corrective action [1]. However, the current surveillance
systems provide an inadequate feedback of nosocomial
infection surveillance data. The studies of the JANIS data
suggest a methodology of assessment of nosocomial
infection surveillance data that will allow infection control
professionals to keep the surveillance systems in good
working order. For further developments of surveillance of
nosocomial infections in Japanese hospitals, we may need
to assess the effect of current surveillance systems on the
incidence and outcome of nosocomial infections in future
studies.
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